NCT02912299

Brief Summary

This study investigates the differens in sodium storage in skin between normal subjects, patients after cardiac surgery and septic patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 13, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 23, 2016

Completed
1 month until next milestone

Study Start

First participant enrolled

November 3, 2016

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 5, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 5, 2017

Completed
Last Updated

September 8, 2017

Status Verified

September 1, 2017

Enrollment Period

10 months

First QC Date

September 13, 2016

Last Update Submit

September 5, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in sodium concentration in skin biopsy between groups

    Skin biopsies will be taken within the described time frame, analysis will take place after all biopsies of all subjects are included

    Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

Secondary Outcomes (8)

  • Immunohistochemistry: outcomes of proteoglycans

    Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  • Immunohistochemistry: binding capacity of proteoglycans

    Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  • Immunohistochemistry: density of lymph capillaries

    Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  • Immunohistochemistry: presence of macrophage influx

    Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  • Quantification of different matrix components / proteoglycans: decorine - if enough tissue is available

    Different for the separate groups: before hip replacement, within 2 hours after CABG and within 12 hours after admission for septic patients

  • +3 more secondary outcomes

Study Arms (3)

Septic patients

Patients admitted to the ICU that fulfill the criteria for the systemic inflammatory response syndrome in the presence of a(n expected) new infection. 2 3mm skin biopsies will be taken, blood and urine analysis will take place and also blood collection for RNA-investigation.

Procedure: Skin biopsiesOther: Blood and urine analysisOther: Blood collection for RNA-investigation

CABG patients

Patients admitted to the ICU after coronary artery bypass grafting. 2 3mm skin biopsies will be taken, blood and urine analysis will take place and also blood collection for RNA-investigation.

Procedure: Skin biopsiesOther: Blood and urine analysisOther: Blood collection for RNA-investigation

Patients before hip replacement

Patients that will undergo a hip replacement because of arthrosis. 2 3mm skin biopsies will be taken, blood and urine analysis will take place and also blood collection for RNA-investigation.

Procedure: Skin biopsiesOther: Blood and urine analysisOther: Blood collection for RNA-investigation

Interventions

Skin biopsiesPROCEDURE

2 3mm skin biopsies will be taken

CABG patientsPatients before hip replacementSeptic patients

Measurement of sodium, potassium and kidneyfunction in blood and urine.

CABG patientsPatients before hip replacementSeptic patients

A blood sample that, in case of relevant differences between groups, could be used for RNA-profiling.

CABG patientsPatients before hip replacementSeptic patients

Eligibility Criteria

Age45 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

* 15 patients admitted to the ICU with systemic inflammatory response syndrom in the presence of a(n expected) new infection * 15 patients admitted to the ICU after coronary artery bypass surgery, matched by gender and age (+/- 10 years) to the septic patients * 15 patients undergoing a hip replacement for arthrosis, matched by gender and age (+/- 10 years) to the septic patients

You may qualify if:

  • years (septic patients), 45-85 years (CABG and hip replacement-patients)
  • Patients undergoing hip replacement: no relevant medical history (i.e. chronic and/or systemic diseases with a suspected influence on sodium / sodium handling)
  • Septic patients: fulfilling the criteria for the systemic inflammatory response syndrome in the presence of a(n expected) new infection

You may not qualify if:

  • Absence of both upper legs
  • Skin disease that makes skin biopsies in healthy skin impossible
  • Subjects with in their history formation of exaggerated scar tissue
  • Subjects suffering from psoriasis or lichen ruber
  • Tattoos covering the whole surface of both upper legs
  • Use of diuretics in the past month
  • Current renal replacement therapy
  • Septic patients: not being sedated
  • Patients undergoing hip replacement: hip replacement because of an inflammatory disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medisch Centrum Leeuwarden

Leeuwarden, Netherlands

Location

Related Publications (5)

  • Polderman KH, Schreuder WO, Strack van Schijndel RJ, Thijs LG. Hypernatremia in the intensive care unit: an indicator of quality of care? Crit Care Med. 1999 Jun;27(6):1105-8. doi: 10.1097/00003246-199906000-00029.

    PMID: 10397213BACKGROUND
  • Waite MD, Fuhrman SA, Badawi O, Zuckerman IH, Franey CS. Intensive care unit-acquired hypernatremia is an independent predictor of increased mortality and length of stay. J Crit Care. 2013 Aug;28(4):405-12. doi: 10.1016/j.jcrc.2012.11.013. Epub 2013 Jan 29.

    PMID: 23369520BACKGROUND
  • Lee JW. Fluid and electrolyte disturbances in critically ill patients. Electrolyte Blood Press. 2010 Dec;8(2):72-81. doi: 10.5049/EBP.2010.8.2.72. Epub 2010 Dec 31.

    PMID: 21468200BACKGROUND
  • Titze J, Krause H, Hecht H, Dietsch P, Rittweger J, Lang R, Kirsch KA, Hilgers KF. Reduced osmotically inactive Na storage capacity and hypertension in the Dahl model. Am J Physiol Renal Physiol. 2002 Jul;283(1):F134-41. doi: 10.1152/ajprenal.00323.2001.

    PMID: 12060595BACKGROUND
  • Titze J, Lang R, Ilies C, Schwind KH, Kirsch KA, Dietsch P, Luft FC, Hilgers KF. Osmotically inactive skin Na+ storage in rats. Am J Physiol Renal Physiol. 2003 Dec;285(6):F1108-17. doi: 10.1152/ajprenal.00200.2003. Epub 2003 Jul 29.

    PMID: 12888617BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Slides for microscopic investigations, containing slices of the skin biopsies. These biopsies are only diagnostic and these are specific and only for study properties. Study involvement will not influence diagnostic or therapeutic interventions that are due to common treatment.

MeSH Terms

Conditions

Hypernatremia

Interventions

Blood Specimen CollectionUrinalysis

Condition Hierarchy (Ancestors)

Water-Electrolyte ImbalanceMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative TechniquesClinical Chemistry TestsDiagnostic Techniques, Urological

Study Officials

  • Christiaan Boerma, MD PhD

    medical center leeuwarden

    PRINCIPAL INVESTIGATOR
  • Jaap van den Born, PhD

    University Medical Center Groningen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 13, 2016

First Posted

September 23, 2016

Study Start

November 3, 2016

Primary Completion

September 5, 2017

Study Completion

September 5, 2017

Last Updated

September 8, 2017

Record last verified: 2017-09

Locations